| Dr Christopher Michael Dress, MD | |
|
11 Racetrack Rd Ne, Ste E4, Fort Walton Beach, FL 32547-1867 | |
| (850) 659-7909 | |
| (850) 583-4875 |
| Full Name | Dr Christopher Michael Dress |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 11 Racetrack Rd Ne, Fort Walton Beach, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962472142 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | ME 87448 (Florida) | Primary |
| 208600000X | Surgery | MD0000031978 (Tennessee) | Secondary |
| Entity Name | Houston County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619026606 PECOS PAC ID: 9436062296 Enrollment ID: O20040219000209 |
News Archive
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
Off-label use of tetanus–diptheria–acellular pertussis vaccine in senior patients results in no more adverse events than the tetanus and diphtheria vaccine, a US study shows.
For more than 100 years, the American Association for Cancer Research has been the premier leader in the basic science of cancer research.
A Consumer Reports survey revealed that more Americans are ignoring their doctor's advice and skipping prescription drugs or medical procedures to save money in 2011 than a year earlier.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Michael Dress, MD 11 Racetrack Rd Ne, Ste E4, Fort Walton Beach, FL 32547-1867 Ph: (850) 659-7909 | Dr Christopher Michael Dress, MD 11 Racetrack Rd Ne, Ste E4, Fort Walton Beach, FL 32547-1867 Ph: (850) 659-7909 |
News Archive
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial, run in centers in Australia and New Zealand, will investigate the antiviral effect of clemizole monotherapy in the absence of interferon.
Off-label use of tetanus–diptheria–acellular pertussis vaccine in senior patients results in no more adverse events than the tetanus and diphtheria vaccine, a US study shows.
For more than 100 years, the American Association for Cancer Research has been the premier leader in the basic science of cancer research.
A Consumer Reports survey revealed that more Americans are ignoring their doctor's advice and skipping prescription drugs or medical procedures to save money in 2011 than a year earlier.
› Verified 9 days ago